kaal:position:2026-07-31-2423

Dynamic Regulation of Cysteine Oxidation and Phosphorylation in Myocardial Ischemia-Reperfusion Injury should be assessed against Kaal's source-bound claim that Regulation is mostly reactive and follows business cycles rather than being proactive; data on venture capital investments lets regulators see where innovation trends are heading and what risks they entail before the disruptive innovation actually materializes. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

regulators with access to venture capital investment data
innovation still at the investment rather than deployment stage
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Dynamic Regulation of Cysteine Oxidation and Phosphorylation in Myocardial Ischemia-Reperfusion Injury

Scholarly basis

kaal:claim:2808132-043
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2469
Mapping ambiguous: true

Topics

innovationdynamic-regulationresearch-methodsrisk-and-incentives

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0010 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 1fcce2cd043d4cb800c0625da96fb6e057769b15091e87e59a9877e65902e701
curl -s https://wulfkaal.github.io/positions/2026-07-31-2423.md | sha256sum